Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Chlorhexidine Acetate 0.015% w/v and Cetrimide 0.15% w/v Irrigation Solution - PA2299/005/001
- Co-Amoxiclav 500mg/100mg Powder for Solution for Injection/Infusion - PA1457/001/001
- Deslor 5mg Film Coated Tablets - PA0711/202/001
- Letrozole 2.5mg Film Coated Tablets - PA2315/109/001
- Letrozole 2.5mg Film Coated Tablets - PA0126/198/001
- Naloxone Hydrochloride 400mcg/ml Solution for Injection or Infusion - PA0073/111/002
- Oramox 125mg/5ml Powder for Oral Suspension - PA0298/019/001
- OxyNorm Dispersa 20mg Orodispersible Tablets - PA1688/006/009
- Uniphyllin Continus 200mg Prolonged Release Tablets - PA1688/011/001
- Valoid 50mg Tablets - PA1142/001/002
The following shortages have been resolved and supply has resumed to the Irish market:
- Aprovel 150mg Tablets - EU/1/97/046/022
- Creon for Children 5000 Gastro Resistant Granules - PA2010/008/004
- Fludarabine Phosphate 25mg/ml Concentrate for Solution for Injection or Infusion (2ml vial) - PA2315/035/001
- Integrilin 2mg/ml Solution for Injection - EU/1/99/109/002
- Kay-Cee-L Syrup 7.5% w/v - PA22637/004/001
- Lercanidipine Clonmel 20mg Film Coated Tablets - PA0126/187/002
- Sirdupla 25mcg/125mcg per Metered Dose Pressurised Inhalation, Suspension - PA0577/201/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.